Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice

1. The role of the renin-angiotensin system (RAS) in cardiac hypertrophy and nephropathy was examined in Tsukuba hypertensive mice (THM) carrying both human renin and angiotensinogen genes, 2, Tsukuba hypertensive mice were treated with 20 mg/kg per day lisinopril, 30 mg/kg per day hydralazine or nothing, Administration of drugs was performed for 6 months from 12 weeks of age; mater intake and urine volume were measured and urine albumin excretion, heart to bodyweight ratio and the glomerulosclerosis index were examined, 3. Systolic blood pressure was significantly lowered by treatment with lisinopril and hydralazine, Urine volume, water intake and urinary albumin excretion were significantly decreased by lisinopril, When hydralazine was administered to THM, these parameters were transiently decreased, but eventually reached almost the same levels as those in the untreated group, The heart to bodyweight ratio was significantly decreased by lisinopril, but not by hydralazine. The glomerulosclerosis index eras significantly lowered by lisinopril, but the index in the hydralazine group was not significantly different from that in the untreated group, 4, These results suggest that the RAS plays an important role in the progression of cardiac hypertrophy in TNM, In addition, the RAS may also play an important role in the progression of nephropathy; however, this may also be partially regulated by elevated blood pressure in the short term.